Amofor is a young company with qualified experts in the area of Amorphous Solid Dispersions (ASD), which gain increasing interest when amorphous drug formulations are needed. It provides services regarding modelling of ASDs, based on acknowledged thermodynamic principles, in order to identify drug compositions that ensure long-term stability even under humid conditions. Thus, their consulting services support the development of safe amorphous formulations of poorly soluble drugs. For more information please refer to this link.
The DDIC was founded in 2017 by the companies Bayer AG, LB Bohle GmbH, Merck KGaA (all Germany) and UCB S.A (Belgium), together with the university partners TU Dortmund and HHU Düsseldorf. INVITE GmbH is leading the consortium. The DDIC fosters international, multi-disciplinary networks in the research area of drug delivery and manufacturing, it promotes pharmaceutical science in close collaboration with academia and pharmaceutical industry along the value chain.